DARE News and Press, Dare Bioscience Inc. From 03/28/24

2024-03-28 08:11:27 ET More on Dare Bioscience Dare Bioscience FY 2023 Earnings Preview Daré Bioscience announces executive team changes Seeking Alpha’s Quant Rating on Dare Bioscience Historical earnings data for Dare Bioscience Financ...

2023 Highlights and Anticipated 2024 Milestones XACIATO™ (clindamycin phosphate) vaginal gel 2% is available by prescription in the United States to treat bacterial vaginosis under license agreement with commercial collaborator Organon Ovaprene® hormone-free mont...

Swire Pacific Ltd. ADR (Class A) (SWRAY) is expected to report for Q4 2023 Troika Media Group Inc. (TRKAQ) is expected to report for quarter end 2023-12-31 American Environmental Partners Inc. (AEPT) is expected to report for quarter end 2023-12-31 Veolia Environnement S.A. ADR (VEOEY...

2024-03-24 08:01:00 ET Westport Fuel Systems ( WPRT ) is set to report its Q4 earnings on Monday after the closing bell. The stock, which has dropped about 24% over a 12-month period, has received a Buy rating from Wall Street analysts, while Seeking Alpha's Quant Rating system has ...

SAN DIEGO, March 21, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a leader in women’s health innovation, today announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, March 28, 2024, to revie...

SAN DIEGO, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, and its collaborator Strategic Science & Technologies, LLC (SST), a Cambridge, MA based novel topical drug delivery company, today annou...

2024-01-29 02:13:56 ET More on Dare Bioscience Daré Bioscience to eliminate CFO and CCO roles to rein in costs Organon says Xaciato now available nationwide Seeking Alpha’s Quant Rating on Dare Bioscience Historical earnings data for Dare Biosc...

2024-01-26 16:50:49 ET More on Dare Bioscience Daré Bioscience, Inc. (DARE) Q3 2023 Earnings Call Transcript Organon says Xaciato now available nationwide Dare Bioscience secures $12M in royalty-backed investment structure Seeking Alpha’s Quant Ra...

SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced changes in company management which includes the retirement of Chief Financial Officer, Lisa Walters-Hoffert, and the resignation of Chief Comme...

SAN DIEGO, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced it has received a grant from the Bill & Melinda Gates Foundation (the foundation) of $750,000 to fund activities related to bacteria-based live...